Thomas Semrad

Thomas Semrad

UNVERIFIED PROFILE

Are you Thomas Semrad?   Register this Author

Register author
Thomas Semrad

Thomas Semrad

Publications by authors named "Thomas Semrad"

Are you Thomas Semrad?   Register this Author

26Publications

489Reads

34Profile Views

Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.

Methods Mol Biol 2018 ;1765:281-297

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-7765-9_18DOI Listing
January 2019

Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.

Thyroid 2018 09 26;28(9):1143-1152. Epub 2018 Jul 26.

4 Department of Otolaryngology, University of California , Davis, Medical Center, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2017.0483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154449PMC
September 2018

Mediating Effect of Postsurgical Chemotherapy on Presence of Dementia and Survival among Patients 65 and Older with Stage III Colon Cancer.

Cancer Epidemiol Biomarkers Prev 2017 10;26(10):1558-1563

Department of Public Health Sciences, School of Medicine, University of California, Davis, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-17-0277DOI Listing
October 2017

Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.

Cancer Treat Res Commun 2017 ;10:21-26

Division of Hematology/Oncology, University of California, Davis Comprehensive Cancer Center, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2016.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519297PMC
January 2017

The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning.

Anticancer Res 2016 Jun;36(6):3013-7

Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, U.S.A.

View Article

Download full-text PDF

Source
June 2016

Molecular testing to optimize therapeutic decision making in advanced colorectal cancer.

J Gastrointest Oncol 2016 Apr;7(Suppl 1):S11-20

1 Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA ; 2 Veterans Administration Northern California Healthcare System, Mather, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2015.094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783624PMC
April 2016

Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings.

Ann Surg Oncol 2015 Dec 23;22 Suppl 3:S855-62. Epub 2015 Jun 23.

Division of Surgical Oncology, Department of Surgery, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4610-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688202PMC
December 2015

ASCO 2015 update on gastrointestinal cancer: Checkpoint inhibition, multimodality strategies and secondary prevention.

Authors:
Thomas J Semrad

Surg Oncol 2015 Dec 11;24(4):371-4. Epub 2015 Nov 11.

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA 95817, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09607404153003
Publisher Site
http://dx.doi.org/10.1016/j.suronc.2015.11.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688068PMC
December 2015

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results.

Int J Clin Oncol 2015 Jun 5;20(3):518-24. Epub 2014 Aug 5.

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-014-0730-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318776PMC
June 2015

Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers.

Expert Opin Investig Drugs 2015 Jun 25;24(6):781-94. Epub 2015 Mar 25.

UC Davis Cancer Center, Division of Hematology and Oncology , Sacramento, CA 95817 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2015.1026963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684166PMC
June 2015

Initial treatment patterns in younger adult patients with differentiated thyroid cancer in California.

Thyroid 2015 May 23;25(5):509-13. Epub 2015 Mar 23.

1 Division of Hematology/Oncology, University of California Davis Comprehensive Cancer Center , Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2014.0610DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426319PMC
May 2015

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.

J Thorac Oncol 2015 Jan;10(1):110-5

*University of California Davis Comprehensive Cancer Center, Sacramento, California; †SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Washington; ‡Humboldt Medical Specialists, Eureka, California; and §Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320001PMC
January 2015

Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors.

Anticancer Drugs 2013 Jul;24(6):636-40

Department of Internal Medicine, Division of Hematology/Oncology, University of California, Davis, Sacramento, California 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3283618b7bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153755PMC
July 2013

Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors.

Invest New Drugs 2012 Oct 21;30(5):2001-7. Epub 2011 Oct 21.

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Cancer Center, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-011-9761-y
Publisher Site
http://dx.doi.org/10.1007/s10637-011-9761-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131984PMC
October 2012

Fibroblast growth factor signaling in non-small-cell lung cancer.

Clin Lung Cancer 2012 Mar 29;13(2):90-5. Epub 2011 Sep 29.

Division of Hematology/Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.08.001DOI Listing
March 2012

Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees.

Cancer 2011 Apr 10;117(8):1755-63. Epub 2011 Jan 10.

Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Sacramento, California 95817, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25668
Publisher Site
http://dx.doi.org/10.1002/cncr.25668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570926PMC
April 2011

Enhancing the clinical activity of sorafenib through dose escalation: rationale and current experience.

Ther Adv Med Oncol 2011 Mar;3(2):95-100

University of California, Davis - Hematology/Oncology, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834010396117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126039PMC
March 2011

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.

J Neurosurg 2007 Apr;106(4):601-8

Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/jns.2007.106.4.601DOI Listing
April 2007